Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jul;51(1):212-23.
doi: 10.1016/j.jhep.2009.03.008. Epub 2009 Mar 31.

Kupffer cells in non-alcoholic fatty liver disease: the emerging view

Affiliations
Review

Kupffer cells in non-alcoholic fatty liver disease: the emerging view

György Baffy. J Hepatol. 2009 Jul.

Abstract

Non-alcoholic fatty liver disease (NAFLD) has become the most common liver disorder of our times. Simple steatosis, a seemingly innocent manifestation of NAFLD, may progress into steatohepatitis and cirrhosis, but this process is not well understood. Since NAFLD is associated with obesity and insulin resistance, mechanisms that link lipid metabolism to inflammation offer insights into the pathogenesis. An important parallel between obesity-related pathology of adipose tissue and liver pertains to the emerging role of macrophages and evidence is growing that Kupffer cells critically contribute to progression of NAFLD. Toll-like receptors, in particular TLR4, represent a major conduit for danger recognition linked to Kupffer cell activation and this process may be perturbed at multiple steps in NAFLD. Steatosis may interfere with sinusoid microcirculation and hepatocellular clearance of microbial and host-derived danger signals, enhancing responsiveness of Kupffer cells. Altered lipid homeostasis in NAFLD may unfavourably affect TLR4 receptor complex assembly and sorting, interfere with signalling flux redistribution, promote amplification loops, and impair negative regulation including alternative activation of Kupffer cells. These events are further promoted by altered adipokine secretion and reactive oxygen species production. Specific targeting of these interactions may provide more effective strategies in the treatment of NAFLD.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Scheme for dysfunctional activation of Kupffer cells in NAFLD
Pattern recognition receptors of Kupffer cells such as TLR4 may be increasingly exposed to exogenous and endogenous danger signals (e.g., LPS, excess fatty acids, modified lipoproteins) via the portal circulation, enhanced by lack of hepatocellular clearance. Pattern recognition pathways may intensify due to altered sorting and signalling, impaired inhibitory circuits, or amplification of redox-sensitive signalling loops. Adipokine imbalance may contribute to these events including low adiponectin levels that fail to suppress intracellular ROS generation. Fat-laden hepatocytes may compromise sinusoid microcirculation leading to entrapment of inflammatory cells. Finally, steatosis may shift away Kupffer cells from alternative activation. Please see details in the text. Solid lines, pro-inflammatory effects; dotted lines, anti-inflammatory mechanisms. Malfunction at one or more steps may promote ‘second hit’ responses, while cellular targeting of these checkpoints has the potential for identifying novel treatment strategies in NAFLD.

References

    1. McCullough AJ. Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol. 2006;40:S17–S29. - PubMed
    1. Ioannou GN. Implications of elevated serum alanine aminotransferase levels: Think outside the liver. Gastroenterology. 2008;135:1935–1944. - PubMed
    1. Cheung O, Sanyal AJ. Hepatitis C infection and nonalcoholic fatty liver disease. Clin Liver Dis. 2008;12:573–585. - PubMed
    1. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36:1349–1354. - PubMed
    1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–438. - PubMed

Publication types